Market Intel: Glucose Monitor Market Set To Explode As Patients Access Better Devices
The market for blood glucose monitoring devices is expected to see double-digit growth, reaching $19.7bn by 2025. This growth is driven largely by the rising demand for smaller, more convenient continuous glucose monitoring (CGMs) devices with improved digital capabilities.
You may also be interested in...
The Israeli company touts its GWave monitor as the world's first non-invasive continuous glucose monitoring technology that uses radiofrequency waves to measure glucose levels in the blood.
Abbott expects the ongoing recovery of medical procedure volumes to continue even as new virus variants are causing COVID-19 cases to increase in some geographies.
The two suits address a total of 17 patents on elements of continuous glucose monitors, or CGMs.